{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:53:24Z","timestamp":1789826004983,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":7012,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1046\/j.1538-7836.2003.00367.x","type":"journal-article","created":{"date-parts":[[2003,10,15]],"date-time":"2003-10-15T02:55:27Z","timestamp":1066186527000},"page":"2191-2197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"title":["Measurement of von Willebrand factor activity: relative effects of ABO blood type and race"],"prefix":"10.1016","volume":"1","author":[{"given":"C.H.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Haff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.J.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Rawlins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.D.","family":"Drews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.","family":"Dilley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Evatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0010","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1182\/blood.V56.4.712.712","article-title":"Serial studies in von Willebrand's disease: variability versus \u2018variants.\u2019","volume":"56","author":"Abildgaard","year":"1980","journal-title":"Blood"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V54.1.117.117","article-title":"Genetics of classic von Willebrand's disease. I. Phenotypic variation within families","volume":"54","author":"Miller","year":"1979","journal-title":"Blood"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1182\/blood.V54.1.137.137","article-title":"Genetics of classic von Willebrand's disease. II. Optimal assignment of the heterozygous genotype (diagnosis) by discriminant analysis","volume":"54","author":"Miller","year":"1979","journal-title":"Blood"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0025","first-page":"362","article-title":"Ristocetin: a new tool in the investigation of platelet aggregation","volume":"26","author":"Howard","year":"1971","journal-title":"Thromb Diath Haemorrh"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0030","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0049-3848(86)90150-7","article-title":"An ELISA test for the binding of von Willebrand antigen binding to collagen","volume":"43","author":"Brown","year":"1986","journal-title":"Thromb Res"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0035","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00001721-199104000-00011","article-title":"Development of a simple collagen based ELISA assay aids in the diagnosis of, and permits sensitive discrimination between Type I and Type II, von Willebrand's disease","volume":"2","author":"Favaloro","year":"1991","journal-title":"Blood Coag Fibrinol"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0040","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1055\/s-0038-1657727","article-title":"von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use","volume":"78","author":"Murdock","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0045","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1055\/s-0037-1614375","article-title":"Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey","volume":"82","author":"Favaloro","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0050","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1055\/s-0037-1615375","article-title":"Assays for von Willebrand factor functional activity: a UK NEQAS Survey","volume":"80","author":"Preston","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0049-3848(98)00078-4","article-title":"Von Willebrand factor: measuring its antigen or function? Correlation between the level of antigen, activity, and multimeric size using various detection systems","volume":"91","author":"Fischer","year":"1998","journal-title":"Thromb Res"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0060","first-page":"89","article-title":"Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level","volume":"37","author":"Orstavik","year":"1985","journal-title":"Am J Hum Genet"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0065","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0070","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0075","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","article-title":"Prevalence of von Willebrand disease in children: a multiethnic study","volume":"123","author":"Werner","year":"1993","journal-title":"J Pediatr"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0080","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1055\/s-0038-1649589","article-title":"Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study","volume":"70","author":"Conlan","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0085","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/01.ATV.14.5.686","article-title":"Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study","volume":"14","author":"Green","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0090","first-page":"630","article-title":"Von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia","volume":"97","author":"Dilley","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ajh.1090","article-title":"Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African-American women","volume":"67","author":"Miller","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0100","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1365-2516.2002.00611.x","article-title":"von Willebrand disease: still an intriguing disorder in the era of molecular medicine","volume":"8","author":"Rodeghiero","year":"2002","journal-title":"Haemophilia"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0105","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1055\/s-0037-1614855","article-title":"Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptives","volume":"82","author":"Kadir","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0110","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00286907","article-title":"Investigation of associations between ABO blood groups and coagulation, fibrinolysis, total lipids, cholesterol, and triglycerides","volume":"48","author":"Colonia","year":"1979","journal-title":"Hum Genet"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0115","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0049-3848(76)90219-X","article-title":"Factor VIII and factor VIII related antigen in normal South African blacks and a black carrier group","volume":"9","author":"Gomperts","year":"1976","journal-title":"Thromb Res"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0120","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","article-title":"Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis","volume":"345","author":"Koster","year":"1995","journal-title":"Lancet"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0125","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1055\/s-0037-1613140","article-title":"Changes in von Willebrand factor and factor VIII levels during the menstrual cycle","volume":"87","author":"Miller","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0130","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1182\/blood.V73.4.990.990","article-title":"Possible effect of Secretor locus on plasma concentration of factor VIII and von Willebrand factor","volume":"73","author":"Orstavik","year":"1989","journal-title":"Blood"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0135","first-page":"334","article-title":"Relationship among Lewis phenotype, clotting factors, and other cardiovascular risk factors in young adults","volume":"125","author":"Green","year":"1995","journal-title":"J Lab Clin Med"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0140","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1365-2141.2002.03270.x","article-title":"Genotype at the Secretor blood group locus is a determinant of plasma von Willebrand factor level","volume":"116","author":"O'Donnell","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0145","first-page":"5","article-title":"High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism","volume":"83","author":"Kraaijenhagen","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0150","first-page":"10","article-title":"Elevation of FVIII in venous thromboembolism is persistent and independent of the acute phase response","volume":"83","author":"O'Donnell","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0155","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1055\/s-0037-1614553","article-title":"Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by the acute phase reactions","volume":"81","author":"Kamphuisen","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0160","doi-asserted-by":"crossref","first-page":"737","DOI":"10.7326\/0003-4819-128-9-199805010-00006","article-title":"Incidence of idiopathic deep vein thrombosis and secondary thromboembolism among ethnic groups in California","volume":"128","author":"White","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0165","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(69)91955-2","article-title":"Venous thromboembolic disease and ABO blood type","volume":"i","author":"Jick","year":"1969","journal-title":"Lancet"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0170","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0049-3848(97)00086-8","article-title":"The prevalence of two genetic traits related to venous thrombosis in whites and African-Americans","volume":"86","author":"Austin","year":"1997","journal-title":"Thromb Res"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0175","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2141.1981.tb07249.x","article-title":"Racial differences in ristocetin-induced platelet aggregation","volume":"49","author":"Buchanan","year":"1981","journal-title":"Br J Haematol"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0180","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.1982.tb01902.x","article-title":"Ristocetin-induced platelet agglutination in Afro-Caribbean and Caucasian people","volume":"50","author":"Mackie","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0185","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1161\/01.ATV.20.8.2024","article-title":"Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time","volume":"20","author":"Souto","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0190","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1182\/blood.V82.2.663.663","article-title":"Human plasma \u03b12-macroglobulin and von Willebrand factor possess covalently linked ABO (H) blood group antigens in subjects with corresponding ABO phenotype","volume":"82","author":"Matsui","year":"1993","journal-title":"Blood"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0195","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1046\/j.1365-2141.2000.02113.x","article-title":"Role of A and B blood group antigens in the expression of adhesive activity of von Willebrand factor","volume":"109","author":"Sarode","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0200","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0022-3476(05)82537-5","article-title":"The relative value of diagnostic studies for von Willebrand disease","volume":"121","author":"Werner","year":"1992","journal-title":"J Pediatr"},{"key":"10.1046\/j.1538-7836.2003.00367.x_bb0205","first-page":"1142","article-title":"Evaluation of two automated methods for measurement of the ristocetin cofactor activity of von Willebrand factor","volume":"87","author":"Miller","year":"2002","journal-title":"Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1538-7836.2003.00367.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622156850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622156850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1046\/j.1538-7836.2003.00367.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:28:26Z","timestamp":1761532106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622156850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["S1538783622156850"],"URL":"https:\/\/doi.org\/10.1046\/j.1538-7836.2003.00367.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2003,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measurement of von Willebrand factor activity: relative effects of ABO blood type and race","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1046\/j.1538-7836.2003.00367.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}